Cargando…

Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Detalles Bibliográficos
Autores principales: Yao, Hang-Ping, Feng, Liang, Suthe, Sreedhar Reddy, Chen, Ling-Hui, Weng, Tian-Hao, Hu, Chen-Yu, Jun, Eun Sung, Wu, Zhi-Gang, Wang, Wei-Lin, Kim, Song Cheol, Tong, Xiang-Min, Wang, Ming-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446402/
https://www.ncbi.nlm.nih.gov/pubmed/30940188
http://dx.doi.org/10.1186/s40425-019-0571-7
_version_ 1783408358972194816
author Yao, Hang-Ping
Feng, Liang
Suthe, Sreedhar Reddy
Chen, Ling-Hui
Weng, Tian-Hao
Hu, Chen-Yu
Jun, Eun Sung
Wu, Zhi-Gang
Wang, Wei-Lin
Kim, Song Cheol
Tong, Xiang-Min
Wang, Ming-Hai
author_facet Yao, Hang-Ping
Feng, Liang
Suthe, Sreedhar Reddy
Chen, Ling-Hui
Weng, Tian-Hao
Hu, Chen-Yu
Jun, Eun Sung
Wu, Zhi-Gang
Wang, Wei-Lin
Kim, Song Cheol
Tong, Xiang-Min
Wang, Ming-Hai
author_sort Yao, Hang-Ping
collection PubMed
description
format Online
Article
Text
id pubmed-6446402
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64464022019-04-15 Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy Yao, Hang-Ping Feng, Liang Suthe, Sreedhar Reddy Chen, Ling-Hui Weng, Tian-Hao Hu, Chen-Yu Jun, Eun Sung Wu, Zhi-Gang Wang, Wei-Lin Kim, Song Cheol Tong, Xiang-Min Wang, Ming-Hai J Immunother Cancer Correction BioMed Central 2019-04-02 /pmc/articles/PMC6446402/ /pubmed/30940188 http://dx.doi.org/10.1186/s40425-019-0571-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Yao, Hang-Ping
Feng, Liang
Suthe, Sreedhar Reddy
Chen, Ling-Hui
Weng, Tian-Hao
Hu, Chen-Yu
Jun, Eun Sung
Wu, Zhi-Gang
Wang, Wei-Lin
Kim, Song Cheol
Tong, Xiang-Min
Wang, Ming-Hai
Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
title Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
title_full Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
title_fullStr Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
title_full_unstemmed Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
title_short Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
title_sort correction to: therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate zt/g4-mmae targeting ron receptor tyrosine kinase for cancer therapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446402/
https://www.ncbi.nlm.nih.gov/pubmed/30940188
http://dx.doi.org/10.1186/s40425-019-0571-7
work_keys_str_mv AT yaohangping correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT fengliang correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT suthesreedharreddy correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT chenlinghui correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT wengtianhao correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT huchenyu correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT juneunsung correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT wuzhigang correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT wangweilin correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT kimsongcheol correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT tongxiangmin correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy
AT wangminghai correctiontotherapeuticefficacypharmacokineticprofilesandtoxicologicalactivitiesofhumanizedantibodydrugconjugateztg4mmaetargetingronreceptortyrosinekinaseforcancertherapy